Cannabis
What Is the Most Vital Part of an Effective Psychedelic Treatment?
![](https://grassnews.net/wp-content/uploads/2020/06/what-is-the-most-vital-part-of-an-effective-psychedelic-treatment.jpg)
Whitefish, Montana–(Newsfile Corp. – June 24, 2020) – CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announces an article discussing psychedelic treatment, aftercare, and Mindleap Health’s innovative approach to the practice.
Image 1: Mindleap Health
To view an enhanced version of Image 1, please visit:
https://orders.newsfilecorp.com/files/6612/58428_8da51df83422581c_001full.jpg
Millions of people have had a psychedelic experience at some point in their life and with new FDA approved medicines and regulatory changes millions more will soon be able to as well. However, without support, it can be challenging to understand and integrate these experiences.
Psychedelic substances are not magic bullets, they are only one tool in the toolbelt of transformational healing and expansion of consciousness. Psychedelics can show people the way and illuminate the pathway towards better mental wellbeing but each person using them needs to be willing to do the work and have the commitment to actually change.
Psychedelic integration is designed to help people plan, prepare, and make sense of psychedelic experiences. Individuals who have participated in a therapeutic psychedelic treatment can benefit from a more comprehensive interpretation of their experience.
[youtube https://www.youtube.com/watch?v=qwEmZW7H05g]
Click to hear Rick Doblin, founder of MAPS, share what the ideal integrative process looks like after taking a psychedelic and how to create the conditions to have the most therapeutic experience as possible.
Cannot view this video? Visit:
https://www.youtube.com/watch?v=qwEmZW7H05g
Psychedelic Therapies will revolutionize mental health
MDMA as a treatment for post-traumatic stress disorder is in Phase 3 clinical trial and is expected to be approved very soon to treat the over 300 million people affected with the condition. Psilocybin for depressive disorders has two drugs in Phase 2 with patient populations over 322 million. All of these treatments are being fast-tracked by the FDA and once approved there will be a major need for a convenient and confidential integration ( psychedelic aftercare ) solution. Currently, there are 90+ psychedelic clinics but that number is growing with companies expanding to be able to meet the upcoming demand.
Mindleap Health: At the Convergence of Tech, Mental Health, and Science
To view an enhanced version of Image 2, please visit:
https://grassnews.net/wp-content/uploads/2020/06/what-is-the-most-vital-part-of-an-effective-psychedelic-treatment-1.jpg
Mindleap Health is at the forefront of this industry with its digital telehealth platform focused on the psychedelic therapy industry. Mindleap has recognized that there is an unmet need for people to access psychedelic integration specialists and is creating the world’s first platform focusing on psychedelic aftercare.
The company’s unique strategy was re-affirmed when it was acquired last week by Mydecine Innovations Group (CSE: MYCO) (OTC Pink: MYCOF) a life sciences company focused on the development and commercialization of products and services that contribute to improved health and wellbeing with a specific focus on psychedelic medicine.
The tools Mindleap is building are the first of their kind to allow the patient to monitor, record, and track their mood and habits (both positive and negative) along with providing access to modern health services, namely integrated coaching to translate psychedelic experiences into positive change.
The system is completely secure and compliant with HIPAA and GDPR mandates and is being developed by a world-class development team with a proven track record.
Finally, Digital Mental Healthcare
As a society, we are becoming more familiar with digital healthcare. Electronic medical records are now the norm. The Covid-19 pandemic has resulted in more usage of video visits to doctors as people sheltered in place to prevent virus spread. A crisis being a catalyst is certainly unfortunate, but it did just make e-visits more mainstream as doctors and patients alike embraced social distancing.
Apropos, already valued at $31.46 billion in 2018, the global telemedicine market is expected to grow at a 19.3% rate by 2025, indicating that adoption is only going to keep accelerating.
Mindleap’s comprehensive platform, expected to launch at the end of summer, includes video visits, appointment scheduling and payment solutions.
Mindleap is also capitalizing on the world’s love of digital technologies, such as smartphones and connected wearable devices, in a newer science dubbed digital phenotyping. By passively collecting data (e.g. sleep patterns, exercise, social patterns), outcomes can be predicted using Artificial Intelligence and Machine Learning. This information subsequently helps healthcare providers optimize support.
To view an enhanced version of Image 3, please visit:
https://orders.newsfilecorp.com/files/6612/58428_8da51df83422581c_004full.jpg
Image 4: The Mindleap App
To view an enhanced version of Image 4, please visit:
https://orders.newsfilecorp.com/files/6612/58428_8da51df83422581c_005full.jpg
It is the epitome of the purpose of Big Data to anonymously help the greater cause by aggregating massive amounts of info. It’s very valuable from both financial and humanitarian perspectives.
The market opportunity as a first mover is tremendous, to say the least. There are more than 577,000 mental health professionals and over 13,000 behavioral health clinics in the U.S. to treat the more than 45 million Americans that have a mental illness.
To put this market opportunity into perspective, consider Livongo. The company has made a splash on Wall Street ($7.4 billion market cap) with an application connecting diabetics to physicians with the strategy that better engagement will promote better health. There are fewer diabetics (~34 million) in the U.S. than people with mental illness.
We’re at a Tipping Point
Thankfully, awareness is growing about the very real medicinal usefulness of psilocybin and other psychedelics. Indeed, they remain illegal as Schedule I drugs currently, but positions are beginning to soften to encourage clinical research. Oakland and Denver have already decriminalized magic mushrooms and over 100 other cities are considering similar action.
Leading research organizations, including Johns Hopkins, have dedicated millions of dollars to study psychedelics, which will only help create tailwinds with every positive development.
The next logical progression is providing patients with the best support possible to help them achieve meaningful changes to their quality of life. That’s exactly what Mindleap Health – and now Mydecine Innovations Group – is bringing to the table by changing the shape of the aftercare model.
Click here to read the full story:
https://www.cannabisfn.com/what-is-the-most-vital-part-of-an-effective-psychedelic-treatment/
Mindleap Health Company Contact:
Nik Vassev
Founder & CEO
About CFN Enterprises Inc.
CFN Enterprises Inc. (OTCQB: CNFN) is a digital media and ecommerce company focused on advancing businesses and brands in highly regulated emerging industries across the globe. CFN connects investors with new market opportunities while helping consumers find innovative products that enhance their lives. Learn more at www.cfnenterprisesinc.com.
CFN Enterprises Inc. Media Contact:
CFN Enterprises Inc.
+001 (833) 420-CNFN
[email protected]
FORWARD-LOOKING STATEMENT
Use of Forward-looking Statements
This press release may contain forward-looking statements from CFN Enterprises Inc. within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when CFN Enterprises Inc. describes the potential acquisition of BarNone assets and the related benefits, its pursuit of M&A opportunities, growth in CBD sales and spending on affiliate marketing, and uses other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions, CFN Enterprises Inc. is using forward-looking statements. These forward-looking statements are based on the current expectations of the management of CFN Enterprises Inc. only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; the regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; or, loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of CFN Enterprises Inc. to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, CFN Enterprises Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting CFN Enterprises Inc., reference is made to CFN Enterprises Inc.’s reports filed from time to time with the Securities and Exchange Commission.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/58428
Cannabis
Europe Medical Cannabis Market Forecast 2024-2032: Tilray, Aurora Cannabis, and GW Pharmaceuticals Dominate the Market Landscape
![](https://grassnews.net/wp-content/uploads/2024/08/europe-medical-cannabis-market-forecast-2024-2032-tilray-aurora-cannabis-and-gw-pharmaceuticals-dominate-the-market-landscape.gif)
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) — The “Europe Medical Cannabis Oil Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2024-2032.” report has been added to ResearchAndMarkets.com’s offering.
The Europe Medical Cannabis Oil market is poised for significant growth, projected to escalate from US$ 0.91 billion in 2023 to US$ 2.40 billion by 2032, advancing at a CAGR of 12.08%. In this comprehensive research report, the market is analyzed by:
- Derivatives;
- Source;
- Application;
- Route of Administration;
- End-user;
- Distribution Channel; and
- Country.
Market Highlights Identified in the Report
- Progressive legalization across Europe is creating a favorable regulatory environment, enhancing market expansion for medical cannabis oil products.
- Germany leads the market with a robust infrastructure and supportive regulations, while other countries like the UK, Italy, and Spain show significant growth potential based on evolving regulatory landscapes and market dynamics.
- Key players such as Tilray, Aurora Cannabis Inc., and GW Pharmaceuticals dominate the market, emphasizing research, strategic partnerships, and innovation to maintain competitive edge amidst evolving industry dynamics.
The medical cannabis oil market has experienced substantial growth as legalization and acceptance of cannabis-based treatments expand globally. Cannabis oil, derived from the cannabis plant through extraction methods, contains cannabinoids such as THC and CBD, known for their therapeutic properties. Increasing recognition of cannabis oil’s potential in alleviating symptoms of various medical conditions, including chronic pain, epilepsy, and anxiety disorders, has driven its adoption in medical settings.
Governments in several countries are progressively legalizing medical cannabis, creating a conducive regulatory environment for market expansion. Additionally, growing consumer awareness about alternative and natural therapies has fueled the demand for cannabis oil products. The market is characterized by diverse product offerings, including full-spectrum and CBD-isolate oils, catering to different therapeutic needs and preferences.
Despite regulatory challenges and stigma associated with cannabis, the medical cannabis oil market continues to evolve, driven by ongoing research, favorable legislative changes, and shifting attitudes toward cannabis-based therapies in healthcare.
Regional Insights
Germany is likely to maintain its leadership position in the European medical cannabis oil market due to its established infrastructure, supportive regulations, and strong healthcare system. Germany legalized medical cannabis in 2017, giving the market a head start compared to many other European countries. This established infrastructure and experience position Germany as a leader in the field. As awareness and acceptance of medical cannabis increase, the number of patients seeking treatment in Germany is steadily rising. This fuels market growth and incentivizes further investment in research and development.
Germany’s regulatory framework for medical cannabis is considered relatively patient-friendly compared to some other European countries. This facilitates access for patients with qualifying conditions. The UK legalized medical cannabis in 2018 and is experiencing an increase in patient access programs. This, coupled with ongoing research, could lead to significant market growth. Italy legalized medical cannabis in 2006 but has faced challenges with availability. As regulations become more streamlined and patient access expands, the Italian market holds significant growth potential. Spain has a well-established medical cannabis industry with a focus on domestic production. As regulations evolve and export opportunities increase, the Spanish market could see a boost.
Competitive Landscape
The Medical Cannabis Oil market is characterized by a vigorous competitive landscape, with prominent entities like Tilray, Aurora Cannabis Inc., GW Pharmaceuticals, Almiral, Bedrocan, and others at the forefront, collectively accounting for approximately 41 % of the overall market share. This competitive milieu is fueled by their intensive efforts in research and development as well as strategic partnerships and collaborations, underscoring their commitment to solidifying market presence and diversifying their offerings.
The primary competitive factors include pricing, product caliber, and technological innovation. As the Medical Cannabis Oil industry continues to expand, the competitive fervor among these key players is anticipated to intensify. The impetus for ongoing innovation and alignment with evolving customer preferences and stringent regulations is high. The industry’s fluidity anticipates an uptick in novel innovations and strategic growth tactics from these leading corporations, which in turn propels the sector’s comprehensive growth and transformation.
Key Topics Covered
Chapter 1. Research Framework
Chapter 2. Research Methodology
Chapter 3. Executive Summary: Europe Medical Cannabis Oil Market
Chapter 4. Europe Medical Cannabis Oil Market Overview
Chapter 5. Europe Medical Cannabis Oil Market Analysis, by Derivatives
Chapter 6. Europe Medical Cannabis Oil Market Analysis, by Source
Chapter 7. Europe Medical Cannabis Oil Market Analysis, by Application
Chapter 8. Europe Medical Cannabis Oil Market Analysis, by Route of Administration
Chapter 9. Europe Medical Cannabis Oil Market Analysis, by End-user
Chapter 10. Europe Medical Cannabis Oil Market Analysis, by Distribution Channel
Chapter 11. Europe Medical Cannabis Oil Market Analysis, by Country
Chapter 12. The UK Medical Cannabis Oil Market Analysis
Chapter 13. Germany Medical Cannabis Oil Market Analysis
Chapter 14. The Netherlands Medical Cannabis Oil Market Analysis
Chapter 15. Italy Medical Cannabis Oil Market Analysis
Chapter 16. Spain Medical Cannabis Oil Market Analysis
Chapter 17. Poland Medical Cannabis Oil Market Analysis
Chapter 18. Rest of Europe Medical Cannabis Oil Market Analysis
Chapter 19. Company Profiles (Company Overview, Financial Matrix, Key Product Landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurora Cannabis Inc.
- Bedrocan
- Biocann
- BIOTA Biosciences LLC
- Cannamedical
- Mary Jane CBD
- Sanity Group GmbH
- Tilray
- Valcon Medical
For more information about this report visit https://www.researchandmarkets.com/r/dh7q46
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cannabis
Cannabis Cultivation Market – Global Food Additives, Oils, Tinctures, Cannabis Indica, Cannabis Sativa Forecast 2024-2030
![](https://grassnews.net/wp-content/uploads/2024/08/cannabis-cultivation-market-global-food-additives-oils-tinctures-cannabis-indica-cannabis-sativa-forecast-2024-2030-1.png)
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) — The “Global Cannabis Cultivation Market by Product (Food Additives, Oils, Tinctures), Type (Cannabis Indica, Cannabis Sativa), Source, Application – Forecast 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The Cannabis Cultivation Market grew from USD 3.64 billion in 2023 to USD 4.15 billion in 2024. It is expected to continue growing at a CAGR of 14.09%, reaching USD 9.17 billion by 2030.
This process requires careful attention to the plant’s life cycle, from germination to harvesting, including the control of environmental factors such as light, temperature, humidity, soil pH, and nutrients. The proliferation in cannabis cultivation has been primarily fueled by the expanding legalization of cannabis for both medical and recreational use, which has driven demand and facilitated the establishment of a legal market. Innovations in cultivation technology, such as hydroponics and LED lighting, have also contributed to the sector’s growth, alongside an increasing social acceptance of cannabis consumption.
However, compliance with diverse state and federal laws and the financial burden of taxation and licensing fees add complexity for cultivators, impeding their development. Thus, the industry is investing in more sustainable practices, such as the use of renewable energy and water recycling systems. Advancements in genetic modification and breeding may lead to new cannabis strains with unique properties, catering to a wider range of consumers. The integration of artificial intelligence and data analytics could further optimize cultivation processes and yield management, enhancing both efficiency and profitability.
Regional Insights
In the Americas, cannabis cultivation has undergone significant transformation, especially in regions where legislation has shifted towards legalization. Canada and certain states of the USA have established robust legal frameworks that govern the production, sale, and consumption of cannabis. These regions host some of the world’s largest cannabis companies, which are heavily regulated, publicly traded, and adhere to strict quality controls. Cannabis cultivation is largely illegal and associated with significant stigma in many APAC countries.
However, locations, including Australia and Thailand, are initiating medical cannabis programs, and there is growing interest in hemp production, typically for CBD oil and industrial uses, in countries such as China. The EMEA region is witnessing a burgeoning medical cannabis market, with countries such as Germany, Israel, and the UK implementing medical programs that have opened doors for cultivation under strict regulations.
Cannabis companies in EMEA often focus on medical-grade products, adhering to pharmaceutical standards such as Good Manufacturing Practices (GMP). The production environment tends towards highly controlled indoor or greenhouse settings. Some African countries, including Lesotho and South Africa, are exploring cannabis cultivation for both medical and economic development purposes, aiming to supply both domestic markets and exports primarily to European countries.
Key Attributes:
Report Attribute | Details |
No. of Pages | 185 |
Forecast Period | 2024 – 2030 |
Estimated Market Value (USD) in 2024 | $4.15 Billion |
Forecasted Market Value (USD) by 2030 | $9.17 Billion |
Compound Annual Growth Rate | 14.0% |
Regions Covered | Global |
Market Dynamics
Market Drivers
- Cannabis Legalization and Rise in Trend of Indoor Cultivation
- Potential Use of Cannabis for Medical Treatment and Scientific Research
- Government Support for Legal Cannabis Cultivation and Education Program
Market Restraints
- Environmental Downside of Cannabis Cultivation and Existence of Illegal Cultivation Practices
Market Opportunities
- Use of AI and ML in Cannabis Cultivation
- Growing Application of Marijuana and Hemp in Various Industries
Market Challenges
- Challenges to Scaling Cannabis Cultivation and Regulatory Pressure
Market Segmentation Analysis
- Product: Availability of high-potency CBD oils for patients with specific therapeutic needs
- Type: Preference for Indica in colder climates and for individuals seeking pain relief and relaxation
- Source: Exponential use of CBD flowers for recreational and medicinal use
- Application: Emerging legalization of cannabis to accelerate its industrial consumption
Industry Insights
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
Key Company Profiles
- ABcann Medicinals, Inc.
- Acreage Holdings
- AgMedica Bioscience Inc.
- Aleafia Health Inc.
- Atlas Growers Ltd.
- Aurora Cannabis Inc.
- Better Group Holdings
- C3 Industries, Inc.
- Cannabis Sativa, Inc.
- Cannatrek Limited
- Canopy Growth Corporation
- Cresco Labs, LLC
- Cronos Group
- Curaleaf Holding Inc.
- Ecofibre Limited
- Gilead Sciences, Inc.
- Green Thumb Industries Inc.
- Harvest Health & Recreation, Inc
- HEXO Operations Inc.
- Jazz Pharmaceuticals PLC
- Lexaria Bioscience
- Mammoth Farms
- Maricann Inc.
- Medical Marijuana, Inc.
- Organigram Holdings Inc.
- SNDL Inc
- Tilray, Inc.
- Trulieve Cannabis Corp
- Ultra Health
- Verano Holdings LLC
- Village Farms International Inc.
Market Segmentation & Coverage
Product
- Food Additives
- Oils
- Tinctures
Type
- Cannabis Indica
- Cannabis Sativa
Source
- Flower/Buds
- Leaves
Application
- Industrial Consumption
- Medical Consumption
- Recreational Consumption
Region
Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
For more information about this report visit https://www.researchandmarkets.com/r/wvy47b
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Cannabis
Global Hemp Based Food Market Size To Worth USD 4.87 Billion By 2033 | CAGR Of 13.12%
![](https://grassnews.net/wp-content/uploads/2024/08/global-hemp-based-food-market-size-to-worth-usd-4-87-billion-by-2033-cagr-of-13-12.png)
New York, United States , Aug. 28, 2024 (GLOBE NEWSWIRE) — The Global Hemp Based Food Market Size is to Grow from USD 1.42 Billion in 2023 to USD 4.87 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 13.12% during the projected period.
Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/5660
Hemp-based food is derived from hemp seeds, which are high in protein, fiber, and healthy fats. These foods, including hemp seeds, hemp oil, and hemp protein powder, have been linked to improved heart health and digestion. Hemp-based foods are gaining popularity as part of a healthy diet, especially among those looking for plant-based and natural food options. Hemp contains fiber as well as a number of vitamins and minerals, such as magnesium, vitamin E, zinc, and iron. Consumption of hemp-based food products improves digestive health, propelling the global hemp-based food market. Hemp-based foods include nut butter, corn chips, and snack bars. This is also benefiting the hemp-based food industry. Hemp seeds are commonly used as supplements and food ingredients all over the world. Hemp seed contains nonpsychoactive but biologically active cannabinoids, including cannabidiol (CBD), which has strong spasmolytic, anxiolytic, and anticonvulsant properties. CBD dietary supplements represent roughly one-third of the global CBD market. Hemp seed has a nutty flavor and contains essential fatty acids, vitamins, minerals, fiber, and the amino acids found in albumin and edestin, two highly absorbable proteins. Hempseed oil is high in polyunsaturated fatty acids, which have been shown to have anti-inflammatory, cancer-fighting, and cardiovascular properties. However, the antioxidant properties of hemp polyphenols currently prevent their absorption in the gut. Also, there is a shortage of processing and planting facilities and a lack of harvesting equipment.
Browse key industry insights spread across 204 pages with 110 Market data tables and figures & charts from the report on the “Global Hemp Based Food Market Size, Share, and COVID-19 Impact Analysis, By Product (Hemp Protein Powder, Hemp Seed Oil, Hemp Seeds, and Others), By Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Online Stores, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.”
Buy Now Full Report: https://www.sphericalinsights.com/checkout/5660
The hemp seeds segment dominates the market with the highest market share of the global hemp based food market during the projected period.
Based on the product, the hemp based food market is divided into hemp protein powder, hemp seed oil, hemp seeds, and others. Among these, the hemp seeds segment dominates the market with the highest market share of the hemp based food market during the projected period. Hemp seeds contain essential nutrients like fatty acids, protein, and fiber. Furthermore, a balanced ratio of omega-3 and omega-6 promotes overall health. Hemp seeds are versatile and can be used in a wide range of recipes. They appeal to a broader audience because they can be eaten raw, cooked, or roasted. They last longer than other hemp-based food products like hemp milk or oil. Furthermore, hemp seeds are easier to cultivate and harvest than other parts of the hemp plant, making them a cost-effective option for farmers.
The supermarkets and hypermarkets segment is anticipated to grow at the fastest pace during the projected period.
Based on the distribution channel, the global hemp based food market is categorized into supermarkets and hypermarkets, convenience stores, online stores, and others. Among these, the supermarkets and hypermarkets segment is anticipated to grow at the fastest pace during the projected period. Supermarkets and hypermarkets are popular shopping destinations that prominently feature hemp-based food products. These retailers use a variety of marketing and promotional strategies, such as loyalty programs, bundled offers, and discounts. Furthermore, they make hemp-derived food products more accessible to a broader range of customers. Supermarkets and hypermarkets provide a one-stop shopping experience, allowing customers to purchase other grocery items as well as hemp-based foods. These supermarkets and hypermarkets sell a variety of hemp-based products, including oils, seeds, and ready-to-eat snacks.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/5660
North America is expected to hold the largest share of the global hemp based food market over the forecast period.
North America is expected to hold the largest share of the global hemp based food market over the forecast period. The presence of a strong supply chain for sourcing, manufacturing, and distributing hemp-based food items in North America is driving market growth. This streamlines market operations and reduces disruption. Also, hemp-based food products are widely available in offline retail channels throughout the region. This retail presence makes the products more accessible to consumers. Apart from that, increasing health consciousness among North American consumers is driving demand for all-natural, nutrient-dense foods.
Asia Pacific is predicted to grow at the fastest pace in the global hemp based food market during the projected period. The growing popularity of Western diets and the rising demand for hemp-based foods. This surge in popularity is primarily due to hemp products’ gluten-free status, which appeals to health-conscious consumers. As more people in this region adopt Western food trends, they are also looking for healthier, alternative options such as hemp-based foods. This shift in consumer preferences is expected to significantly increase the demand for hemp-based products in Asia-Pacific in the coming years.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global hemp based food market are Hempfoods Ltd., Tilray, Inc., GFR Ingredients, Hemp Foods Australia Pty Ltd, Aurora Cannabis Inc., Naturally Splendid Enterprises Ltd., Isodiol International Inc, Navitas LLC, Nutiva, Planet Based Foods Global Inc., T12 Holdings Pty Ltd., Agropro, Compass Diversified, Canopy Growth Corporation, Hempco Inc., Cool Hemp, and Other key vendors.
Get Discount At @ https://www.sphericalinsights.com/request-discount/5660
Recent Developments
- In March 2023, Planet Based Foods Global Inc. announced that its wholly-owned subsidiary Planet Based Foods has expanded into the non-dairy frozen dessert category by introducing new hemp-based and organic vegan ice cream at Natural Products EXPO West.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global hemp based food market based on the below-mentioned segments:
Global Hemp Based Food Market, By Product
- Hemp Protein Powder
- Hemp Seed Oil
- Hemp Seeds
- Others
Global Hemp Based Food Market, By Distribution Channel
- Supermarkets and Hypermarkets
- Convenience Stores
- Online Stores
- Others
Global Hemp Based Food Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Browse Related Reports
Global Superfood Market Size, Share, and COVID-19 Impact Analysis, By Type (Superfruits, Superseeds and Supergrains, Edible Seaweed, and Others), By Distribution Channel (Store-Based, Non-Store Based), By Application (Beverages, Snacks, Bakery & Confectionery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Ginger Oil Market Size, Share, and COVID-19 Impact Analysis, By Nature (Organic and Conventional), By Application (Cosmetics & Personal Care, Pharmaceuticals, Household, and Others), By Distribution Channel (Hypermarkets/Supermarkets, Specialty Stores, Mass Grocery Stores, Online Retail, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
Global Smart Card Materials Market Size, Share, and COVID-19 Impact Analysis, By Material (Polyvinyl Chloride (PVC), Polycarbonate (PC), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate-Glycol (PETG), and Others), By Type (Contact Cards, Contactless Cards, and Multi-Component Cards), By Application (BFSI, Government, Telecommunication, Retail, Healthcare, Hospitality, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Pregelatinized Starch Market Size, Share, and COVID-19 Impact Analysis, By Source (Corn, Wheat, Potato, and Others), By Application (Food & Beverage, Pharmaceutical, Cosmetics, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: [email protected], [email protected]
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
-
Cannabis2 weeks ago
Silly Nice Announces Launch of New 1G 510 Vape Cartridge and 2G All-In-One Vape in New York Dispensaries This September
-
Cannabis2 weeks ago
Cannabis Cultivation Market – Global Food Additives, Oils, Tinctures, Cannabis Indica, Cannabis Sativa Forecast 2024-2030
-
Cannabis1 week ago
Europe Medical Cannabis Market Forecast 2024-2032: Tilray, Aurora Cannabis, and GW Pharmaceuticals Dominate the Market Landscape
-
Cannabis2 weeks ago
Global Hemp Based Food Market Size To Worth USD 4.87 Billion By 2033 | CAGR Of 13.12%
-
Innocan1 week ago
Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options
-
Indivior4 days ago
Indivior Provides Update on Aelis Farma’s Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder